Simpson Thacher is representing Blackstone in connection with its acquisition of the entire equity stake in AYUMI Pharmaceutical. The acquisition will mark Blackstone’s first control private…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
